Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: Findings from the chronic renal insufficiency cohort (CRIC) study

American Journal of Nephrology

Volumn 33, Issue 6, 2011, Pages 477-484

  Townsend, Raymond R ^a,g   Anderson, Amanda H ^a   Chen, Jing ^b   Gadebegku, Crystal A ^c   Feldman, Harold I ^a   Fink, Jeffrey C ^d   Go, Alan S ^e   Joffe, Marshall ^a   Nessel, Lisa A ^a   Ojo, Akinlolu ^c   Rader, Daniel J ^a   Reilly, Muredach P ^a   Teal, Valerie ^a   Teff, Karen ^a   Wright, Jackson T ^f   Xie, Dawei ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e KAISER PERMANENTE   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiovascular disease; Chronic kidney disease; Chronic Renal Insufficiency Cohort (CRIC) Study; Metabolic syndrome

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, STATISTICAL; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES; YOUNG ADULT;

EID: 79955090507     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000327618     Document Type: Article

References (24)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351: 1296-1305.
2. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005;293:1737-1745.
3. Muntner P, He J, Hamm L, Loria C, Whelton PK: Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13:745-753. (Pubitemid 34183941)
4. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS: Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006;145:237-246. (Pubitemid 46768607)
5. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689. (Pubitemid 32893993)
6. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716. (Pubitemid 35403784)
7. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-1778. (Pubitemid 40923091)
8. Galassi A, Reynolds K, He J: Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-819. (Pubitemid 44415613)
9. Garni AS, Witt BJ, Howard DE, Erwin PJ, Garni LA, Somers VK, Montori VM: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-414. (Pubitemid 46135879)
10. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167-174.
11. Lea J, Cheek D, Thornley-Brown D, Appel L, Agodoa L, Contreras G, Gassman J, Lash J, Miller ER III, Randall O, Wang X, McClellan W: Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African-Americans. Am J Kidney Dis 2008; 51:732-740. (Pubitemid 351626250)
12. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, He J, Hostetter T, Hsu CY, Jamerson K, Joffe M, Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER III, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT: The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods. J Am Soc Nephrol 2003; 14:S148-S153. (Pubitemid 36750511)
13. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
14. Behrens T, Taeger D, Wellmann J, Keil U: Different methods to calculate effect estimates in cross-sectional studies. A comparison between prevalence odds ratio and prevalence ratio. Methods Inf Med 2004;43:505-509. (Pubitemid 40040333)
15. Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES-III participants age 50 years and older. Diabetes 2003; 52:1210-1214. (Pubitemid 36523358)
16. Bertoni AG, Wong ND, Shea S, Ma S, Liu K, Preethi S, Jacobs DR Jr, Wu C, Saad MF, Szklo M: Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2007;30:2951-2956. (Pubitemid 350083150)
17. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359. (Pubitemid 34251969)
18. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005;16:2134-2140. (Pubitemid 41716445)
19. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U: Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000;278:F817-F822. (Pubitemid 30351084)
20. Perlstein TS, Gerhard-Herman M, Hollenberg NK, Williams GH, Thomas A: Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects. J Am Soc Nephrol 2007; 18: 944-951. (Pubitemid 46434511)
21. Kaplan NM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-1520. (Pubitemid 19177621)
22. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304. (Pubitemid 41242486)
23. Natali A, Pucci G, Boldrini B, Schillaci G: Metabolic syndrome: at the crossroads of cardiorenal risk. J Nephrol 2009;22:29-38.
24. Covic A, Gusbeth-Tatomir P, Goldsmith DJ: The challenge of cardiovascular risk factors in end-stage renal disease. J Nephrol 2003; 16:476-486. (Pubitemid 38120457)